Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Tumor Cell–Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells
2016
Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
2012
Subtypes of Breast Cancer Show Preferential Site of Relapse
2008
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
2010
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI
2011
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
2014
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Anthracycline-Induced Cardiomyopathy
2010
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Breast cancer
2016 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Metronomic therapy for breast cancer
2004
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Cancer Therapy-Induced Left Ventricular Dysfunction: Interventions and Prognosis
2014
Biomarker Approach to the Detection and Cardioprotective Strategies During Anthracycline Chemotherapy
2011
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
2010
Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?
2008
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis
2005
The biology of VEGF and its receptors
2003 Standout
Silicon Micro‐ and Nanofabrication for Medicine
2013
Role of Biomarkers in Chemotherapy-Induced Cardiotoxicity
2010
Significance, detection and markers of disseminated breast cancer cells
2006
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Risk factors for brain relapse in patients with metastatic breast cancer
2004
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
2012
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer
2016
Angiogenesis in life, disease and medicine
2005 StandoutNature
Malignant Gliomas in Adults
2008 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Cancer micrometastases
2009
Exosomes in tumor microenvironment influence cancer progression and metastasis
2013
The multifaceted circulating endothelial cell in cancer: towards marker and target identification
2006
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Sepsis-Associated Myocardial Dysfunction
2006
Cardiovascular Complications of Cancer Therapy
2009
Gastric cancer
2020 Standout
Neuroblastoma
2007 Standout
Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer
2007
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
2000
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma
2003
Biomarkers in Heart Failure
2008 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Implications of elevated cardiac troponin t in ambulatory patients with heart failure: a prospective analysis
2004
Cancer drugs and the heart: importance and management
2012
Minor Increases in Plasma Troponin I Predict Decreased Left Ventricular Ejection Fraction after High-Dose Chemotherapy
2003
Cancer Therapy–Induced Cardiac Toxicity in Early Breast Cancer
2012
Free-Standing Kinked Silicon Nanowires for Probing Inter- and Intracellular Force Dynamics
2015 StandoutNobel
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Redefining the Target: Chemotherapeutics as Antiangiogenics
2001
Identification and Clinical Significance of Circulating Endothelial Progenitor Cells in Human Non–Small Cell Lung Cancer
2006
Effects of Aging and Hypoxia-Inducible Factor-1 Activity on Angiogenic Cell Mobilization and Recovery of Perfusion After Limb Ischemia
2007 StandoutNobel
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy
2006
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.
2002
Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy
2003
Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded
2005
Chemotherapy for advanced gastric cancer
2017 Standout
Breast Cancer Treatment
2019 Standout
Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.
2002
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
2013
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
2007
Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure
2003
Antiangiogenics: The Potential Role of Integrating This Novel Treatment Modality With Chemoradiation for Solid Cancers
2007
Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?
2006 Science
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
2016
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Metabolic reprogramming and cancer progression
2020 StandoutScience
Cardiotoxicity of Cancer Therapy
2005
A Comparative Analysis of Low-Dose Metronomic Cyclophosphamide Reveals Absent or Low-Grade Toxicity on Tissues Highly Sensitive to the Toxic Effects of Maximum Tolerated Dose Regimens
2004
Monitoring of Anthracycline-Induced Cardiotoxicity
2007
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Cardiac MRI in the Assessment of Cardiac Injury and Toxicity From Cancer Chemotherapy
2013
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
2010
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
2006
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
2007
Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.
2002
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
2018 Standout
Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.
2003
Cardiac toxicity in cancer survivors
2013
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy
2004
Tamoxifen After Adjuvant Chemotherapy for Premenopausal Women With Lymph Node-Positive Breast Cancer: International Breast Cancer Study Group Trial 13-93
2006
Cardiovascular Complications of Cancer Therapy
2004
Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity
2005
Works of Saverio Cinieri being referenced
Endocrine therapy in post-menopausal women with metastatic breast cancer: From literature and guidelines to clinical practice
2016
Breast carcinoma in elderly women
2004
Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy
2002
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels
2002
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
2000
Adjuvant systemic therapies in women with breast cancer:an audit of clinical practice in Italy
2003
Targeted agents to reverse resistance to endocrine therapy in metastatic breast cancer: Where are we now and where are we going?
2012
Assessing Tumor Angiogenesis
2004
Epirubicin (E) in combination with cisplatin (CDDP) and capecitabine (C) versus docetaxel (D) combined with 5-fluorouracil (5-FU) by continuous infusion as front-line therapy in patients with advanced gastric cancer (AGC): Preliminary results of a randomized phase II trial of the Gruppo Oncologico Dell'Italia Meridionale.
2011
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review.
2012
Clinical Activity and Cardiac Tolerability of Non-Pegylated Liposomal Doxorubicin in Breast Cancer: A Synthetic Review
2011
Multicycle Dose-Intensive Chemotherapy for Women With High-Risk Primary Breast Cancer: Results of International Breast Cancer Study Group Trial 15-95
2006
Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
2003
Mammaglobin Expression in Leukapheresis Products Is a Predictive Marker of Poor Prognosis in Women with High-Risk Breast Cancer
2004